Asian Pac J Cancer Prev, 16 (3), 923-926
IntroductionThe term preinvasive disease of the cervix (PCD) was first defined in 1947 (Pund, 1947). Despite the fact that epithelial changes give the appearance of invasive cancer on the cervix, lesions confined to the epithelium are to be noted in PCD. After PCD is defined, some studies have shown that if these lesions did not treat cervical dysplasia, it progresses to cervical cancer (Koss et al., 1963). Therefore, when the preinvasive lesions could be diagnosed before the stage of the invasive cervical cancer, this early detection allows easy treatment (Richart & Sciarra, 1968).Cervical cancer (CC) is still one of the most frequent malignancies in women worldwide (Siegel, Naishadham & Jemal, 2013). In CC, like the other cancers, the host response to malignant tumors comprises not only changes in the microenvironment, but also systemic alterations (Tavares-Murta et al., 2010). One of the important systemic alterations is inflammation. Inflammation is a nonspecific feature of cancer and plays an important role in various aspects of cancer involving cancer initiation, promotion, progression, metastasis and clinical features (Babu et al., 2012). Therefore, inflammatory markers were studied in various cancer types as indicators of invasion (Acmaz et al., 2014).The platelet-lymphocyte ratio (PLR) is an inflammatory marker and has been studied in uterine cancer and uterine cancer precursor lesions (Acmaz et al., 2014). The aim of